Colgate-Palmolive (NYSE:CL) has been given a consensus recommendation of “Hold” by the twenty analysts that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, fifteen have given a hold rating and four have assigned a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $76.38.
A number of equities analysts recently issued reports on the company. SunTrust Banks raised Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their price target for the company from $65.00 to $85.00 in a report on Wednesday, October 11th. Citigroup lowered their price target on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a report on Thursday, November 2nd. Stifel Nicolaus set a $73.00 price target on Colgate-Palmolive and gave the company a “hold” rating in a report on Sunday, October 29th. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a report on Sunday, October 8th. Finally, Zacks Investment Research upgraded Colgate-Palmolive from a “sell” rating to a “hold” rating in a research note on Wednesday, November 8th.
Shares of Colgate-Palmolive (NYSE CL) traded up $0.76 on Thursday, reaching $72.76. The company had a trading volume of 2,703,577 shares, compared to its average volume of 3,602,415. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. The firm has a market capitalization of $63,860.00, a P/E ratio of 25.09, a price-to-earnings-growth ratio of 3.30 and a beta of 0.80. Colgate-Palmolive has a 52-week low of $63.43 and a 52-week high of $77.27.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.73. The firm had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The firm’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.73 earnings per share. equities research analysts predict that Colgate-Palmolive will post 2.88 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd were paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.20%. The ex-dividend date was Friday, October 20th. Colgate-Palmolive’s dividend payout ratio is currently 61.78%.
In other news, insider Victoria L. Dolan sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, November 9th. The stock was sold at an average price of $73.07, for a total transaction of $730,700.00. Following the completion of the sale, the insider now owns 60,528 shares in the company, valued at $4,422,780.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CMO Mukul Deoras sold 7,500 shares of the company’s stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $73.28, for a total value of $549,600.00. Following the sale, the chief marketing officer now owns 45,217 shares of the company’s stock, valued at approximately $3,313,501.76. The disclosure for this sale can be found here. In the last quarter, insiders sold 173,673 shares of company stock valued at $12,629,293. 1.02% of the stock is owned by company insiders.
Institutional investors have recently added to or reduced their stakes in the company. Blue Chip Partners Inc. raised its position in Colgate-Palmolive by 0.4% in the second quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock worth $134,000 after acquiring an additional 8 shares in the last quarter. Cue Financial Group Inc. raised its position in Colgate-Palmolive by 0.3% in the second quarter. Cue Financial Group Inc. now owns 4,854 shares of the company’s stock worth $360,000 after acquiring an additional 14 shares in the last quarter. Cornerstone Financial Partners LLC raised its position in Colgate-Palmolive by 0.5% in the second quarter. Cornerstone Financial Partners LLC now owns 3,813 shares of the company’s stock worth $282,000 after acquiring an additional 19 shares in the last quarter. M Holdings Securities Inc. raised its position in Colgate-Palmolive by 0.4% in the first quarter. M Holdings Securities Inc. now owns 5,366 shares of the company’s stock worth $393,000 after acquiring an additional 21 shares in the last quarter. Finally, AlphaMark Advisors LLC raised its position in Colgate-Palmolive by 1.5% in the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after acquiring an additional 25 shares in the last quarter. Institutional investors and hedge funds own 73.22% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Colgate-Palmolive (CL) Receives $76.38 Average Target Price from Analysts” was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The legal version of this story can be read at https://www.dispatchtribunal.com/2017/12/07/colgate-palmolive-cl-receives-76-38-average-target-price-from-analysts.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.